Ticker brief
SABS
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
5
authors 14d
5
crowd 14d
+0.61
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-06 → 2026-10-13 · now +0.40 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @be4_the_h3rd | C | -3.02 | 1 | +0.75 |
| @GoldmanBanker | C | -1.56 | 1 | +0.60 |
| @BioStocks | C | -1.77 | 1 | +0.50 |
| @OzmosiHealth | C | · | 1 | +0.50 |
| @BiopharmIQ | B | · | 1 | +0.20 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-13 | @BiopharmIQ | +0.20 | Biotech opening-news board pairs catalysts with contemporaneous price moves. | · | tweet ↗ |
| 2026-10-13 | @OzmosiHealth | +0.50 | SAB BIO received FDA Fast Track designation for SAB-142 in type 1 diabetes. | · | tweet ↗ |
| 2026-10-13 | @BioStocks | +0.50 | FDA granted Fast Track designation to SAB-142. | · | tweet ↗ |
| 2026-10-06 | @GoldmanBanker | +0.60 | Take a speculative long position in SABS near $3.06. — Explicit speculative entry recommendation with a stated price. | · | tweet ↗ |
| 2026-10-06 | @be4_the_h3rd | +0.75 | Opened a new speculative long in SABS. — Declares SABS a new long based on plague-related optionality. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.